Dialog Box

our board

Ovarian Cancer Australia’s board of directors dedicates a huge amount of both professional and personal time and energy to our vision.

Meghan Speers


Meghan is a partner at Deloitte. She is a Chartered Accountant and solicitor and an ovarian cancer survivor, having been diagnosed at 29 years of age. A mother of two, Meghan has been actively involved in raising awareness about ovarian cancer, working closely with Ovarian Cancer Australia, for more than 10 years.

Meghan sees joining the Board of Ovarian Cancer Australia as a chance to give back to an organisation that provided so much support and ensured she didn’t battle ovarian cancer alone.  Her ambition is to bring her commercial business expertise with a consumer’s insight and to assist Ovarian Cancer Australia to achieve its bold 2025 vision to reduce the incidence and improve the survival rates of ovarian cancer.

NED and Professor of Practice, Juliet Bourke


Juliet Bourke is a Non Executive Director and Professor of Practice in the UNSW School of Management and Governance in the Business School. Chair of the AICD 30% Club Education Working Group, and a board member on the Global Institute for Women’s Leadership King’s College London (established and chaired by former Prime Minister Julia Gillard AC), and qChange (a US based tech-start up).  

Formerly a partner at Deloitte (2011-2020), and the co-founder of Aequus Partners (2000-2011), Juliet has advised over 200 global organisations on people and culture issues, including American Airlines, APRA, the Australian Army, BHP, Gilead Sciences, Johson & Johnson, Macquarie Group, Qantas, the RBA, Toyota, the United Nations and Woodside. She has served on three Diversity Councils, namely for the RBA, the Australian Navy and Deloitte Australia. Juliet started her career as a lawyer, firstly working in criminal law for the Commonwealth Director of Prosecutions and then in employment law. 

Juliet is a TEDx speaker, a 2019 Australian Financial Review Top 100 Women of Influence and is well known for her thought leadership on diversity and inclusion. She has published in the Harvard Business Review, the Australian Financial Review and The Guardian. Her most recent book (published by the Australian Institute of Company Directors) is “Which two heads are better than one? The extraordinary power of diversity of thinking and inclusive leadership” (2021)).  

Juliet holds a BA (Psychology Major), LLB, LLM (with Hons) and is a final year PhD candidate (Business School, Brunel University London).   

Richard Gosper


Richard Gosper is an Associate Partner at Bain & Company, a global management consulting firm and brings experience in strategy development and digital acumen. His experience working with complex organisations will be beneficial as Ovarian Cancer Australia continues to influence and participate within the broader cancer ecosystem. 

Andrew Jolly


Andrew Jolly is a Director at PwC based in Melbourne. He is an experienced technology professional with significant senior digital and program delivery experience across the private and public sectors. Andrew’s experience assisting complex organisations with digital transformation and delivery will be beneficial as Ovarian Cancer Australia continues to navigate the challenging and exciting changing environment.

Marise Maltman


Marise Maltman leads the Office of the CFO cloud solution for Asia Pacific and Japan at Workday.

Marise's international experience working with complex organisations will be beneficial as Ovarian Cancer Australia continues to navigate the challenging and exciting changing environment.

While Marise started as an auditor, she changed focus in 2012 using deep problem-solving and analytical skills to work with companies to enable change (often from ‘developing’ to leading practices), resolve complex business issues and lead finance transformation. Being an auditor for 20+ years and working in various industries provided a great springboard to something new. 

Marise has a solid track record working with executives in various industries resolving intricate finance and business issues using years of varied experience to consistently deliver successful outcomes and manage multiple stakeholders. In her current role she works directly with key finance executives in some of Australia’s most iconic companies to help improve the effectiveness of their finance function in the context of business challenges to facilitate and create effective solutions and efficiencies.

Melissa McClusky


Melissa McClusky is a partner at KPMG. With over 25 years of management and leadership experience in a career spanning both public and private sector organisations, Mel brings a strong focus on digital programs and excellence in service delivery.

Professor Karen Strickland


Karen Strickland is Executive Dean, School of Nursing and Midwifery at Edith Cowan University. She is an experienced academic nurse leader with significant clinical, academic and research experience across the health, higher education, and social service sectors.

Karen trained as a nurse in Edinburgh, where she worked in various surgical units and Marie Curie Cancer Care Hospice, before moving into academic positions. Karen’s research is focused on the lived experiences of people affected by cancer, seeking to understand how health care professionals can better support people and their families who are affected by cancer. Karen is recognised as an expert in the fields of cancer and palliative care nursing through various appointments including as invited member of the Professional Advisory Council of the Cancer Nurses Society of Australia and two Visiting Professor appointments with international universities in New Zealand and Scotland.  

Karen has held a number of board level appointments including Board Chair to Canberra College in the ACT, and previously as Non-Executive Director of Alcohol and Drugs Action, Aberdeen, Scotland. Within the University of Canberra, she is a Professorial member of the University Academic Board and Education Committees. Karen holds statutory appointments as member of the Nursing and Midwifery Board of Australia ACT Board, and as Council of Deans of Nursing and Midwifery member of the Commonwealth Nursing and Midwifery Strategic Reference Group. 

Karen is a registered nurse and holds a PhD in Nursing from Edinburgh Napier University (Scotland) as well as being a Fellow of the European Academy of Nursing and the Higher Education Academy (UK).  

Ian Heard 

Board Observer